Search

Your search keyword '"Joke, Bilcke"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Joke, Bilcke" Remove constraint Author: "Joke, Bilcke" Topic human medicine Remove constraint Topic: human medicine
45 results on '"Joke, Bilcke"'

Search Results

1. Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries

2. Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: a multi-country prospective cohort study in Europe

3. Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness

4. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

5. Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting : a modeling study

6. Authors' Reply to Comment on 'Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine'

7. A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic Evaluations

8. Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi : a mathematical modelling study

9. Belgian population norms for the EQ-5D-5L, 2018

10. Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine

11. Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice

12. Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination

13. Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015)

14. Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression

15. Economic costs analysis of uncomplicated malaria case management in the Peruvian Amazon

16. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study

17. Case fatality rate of enteric fever in endemic countries : a systematic review and meta-analysis

18. Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium

19. Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC

20. Childhood varicella-zoster virus vaccination in Belgium: Cost-effective only in the long run or without exogenous boosting?

21. Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice?

22. Detection of human papillomavirus DNA in urine. A review of the literature

23. Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models

24. Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and 'No Medical Care' Disease Impact in Belgium

25. The health and economic burden of rotavirus disease in Belgium

26. The cost-effectiveness of pneumococcal vaccination in healthy adults over 50 : an exploration of influential factors for Belgium

27. Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium?

28. Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014

29. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community

30. Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds

31. Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium

32. Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians

33. Cost-effectiveness of socioeconomic support as part of HIV care for the poor in an urban community-based antiretroviral program in Uganda

34. The health and economic burden of chickenpox and herpes zoster in Belgium

35. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium

36. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom

37. Response to comment on article by Jit et al. : The cost effectiveness of rotavirus vaccination : comparative analyses for five European countries and transferability in Europe

39. The burden of rotavirus acute gastroenteritis in Europe

40. An update to 'The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe'

42. Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis

43. The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

45. Cost-effectiveness of varicella and zoster vaccination in England&Wales: importance measures for correlated parameters

Catalog

Books, media, physical & digital resources